Apoptosis in atherosclerosis: Focus on oxidized lipids and inflammation

Current Opinion in Lipidology

Volumn 12, Issue 5, 2001, Pages 535-541

  Martinet, W ^a   Kockx, M M ^a  

^a MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOCHROME C; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN P53; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROTECTION; DNA DEGRADATION; ENDOTHELIUM CELL; HUMAN; LIPID OXIDATION; MACROPHAGE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; FOAM CELLS; HUMANS; INFLAMMATION; LIPID METABOLISM; LIPOPROTEINS, LDL; OXIDATIVE STRESS; THERAPEUTICS;

EID: 0034775456     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200110000-00009     Document Type: Review

References (66)

1. Apoptosis in the vascular wall and atherosclerosis
2. Apoptosis in the vasculature: Mechanisms and functional importance
3. The role of apoptosis in vascular disease
4. The regulation of vascular smooth muscle cell apoptosis
5. Atherosclerosis
6. Apoptosis and related proteins in different stages of human atherosclerotic plaques
7. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques
8. Atherosclerosis in APOE*3-Leiden transgenic mice: From proliferative to atheromatous stage
9. Apoptosis in atherosclerosis: Beneficial or detrimental?
10. The biochemistry of apoptosis
11. Modified LDL: Trigger of atherosclerosis and inflammation in the arterial intima
12. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: Molecular mechanisms and effects on matrix interactions
13. Oxidized low-density lipoprotein is associated with apoptosis of vascular smooth muscle cells in human atherosclerotic plaques
14. Regulatory effects of aggregated LDL on apoptosis during foam cell formation of human peripheral blood monocytes
15. Regulation of macrophage-specific gene expression by degenerated lipoproteins
16. Induction of ubiquitin-conjugating enzyme by aggregated low density lipoprotein in human macrophages and its implications for atherosclerosis
17. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent
18. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells
19. Endothelial cell apoptosis induced by oxidized LDL is associated with the downregulation of the cellular caspase inhibitor FLIP
20. Apoptosis of vascular smooth muscle cells induced by cholesterol and its oxides in vitro and in vivo
21. Oxysterols induce mitochondrial conformational change and cytochrome C release in SMC undergoing apoptosis
22. Fas/Fas ligand-mediated death pathway is involved in oxLDL·induced apoptosis in vascular smooth muscle cells
23. Oxidized low density lipoprotein induces apoptosis via generation of reactive oxygen species in vascular smooth muscle cells
24. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins
25. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF
26. Oxidation-dependent effects of oxidized LDL: Proliferation or cell death
27. Differential effects of low density lipoproteins on insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells
28. Expression of class A scavenger receptor inhibits apoptosis of macrophages triggered by oxidized low density lipoprotein and oxysterol
29. Large scale gene expression analysis of cholesterol-loaded macrophages
30. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity
31. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: Evidence that oxidation-specific epitopes mediate macrophage recognition
32. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
33. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta
34. Mast cell chymase induces apoptosis of vascular smooth muscle cells
35. Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death
36. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques
37. Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries
38. Platelet phagocytosis leads to induction of inducible nitric oxide synthase via a β-secretase·mediated pathway
39. DNA damage and repair in human atherosclerotic plaques
40. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering
41. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques
42. Genomic instability in the type II TGF. beta 1 receptor gene in atherosclerotic and restenotic vascular cells
43. Defying death after DNA damage
44. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice
45. Fas-induced caspase denitrosylation
46. Free cholesterol loading of macrophages induces apoptosis involving the Fas pathway
47. Vascular endothelial cells and smooth muscle ceils differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death: Implications for vascular disease and therapy
48. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis
49. xlAP induces cell-cycle arrest and activates nuclear factor·κB: New survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells
50. Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells
51. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation
52. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages
53. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation
54. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal
55. Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma
56. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro
57. Statins alter smooth muscle accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits
58. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization
59. Decreased apoptosis and tissue factor expression after lipid lowering
60. From bench to clinic with apoptosis-based therapeutic agents
61. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenicity
62. Release of active tissue factor by human arterial smooth muscle cells
63. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells
64. Functional genomics and DNA array techniques in atherosclerosis research
65. Inhibition of apoptosis by ischemia-reperfusion prevents inflammation
66. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7